While vaccination programmes continue to scale up around the world, therapeutics play a key role in saving lives, freeing up capacity in intensive care units and treating patients living with  long-COVID.

The pharmaceutical industry is working around the clock to develop new tools to help patients and clinicians fight COVID-19. There are currently nearly 3000 clinical trials exploring therapeutics for treating COVID patients and around 61 therapeutic candidates such as anti-virals, monoclonal antibodies, anti-hypertensives, anti-inflammatories, immunomodulators, anti-thrombotics and steroids in the latter stages of development.

The European Commission's COVID-19 Therapeutics Strategy aims to accelerate the continued development, delivery and availability of therapeutics for use in the fight against COVID-19 in Europe and around the the world.

Join us on 29 June 2021 to learn more about the importance of therapeutics in mitigating the impact of COVID-19 on people, on health systems and on society.